Publications

Chemogenetic management of neuropathic pain.

Basbaum A

2017
Chemogenetic management of neuropathic pain.

Basbaum A

2017
Ocrelizumab and Other CD20+ B-Cell-Depleting Therapies in Multiple Sclerosis.

Gelfand JM, Cree BAC, Hauser SL

2017
Genetic Characterization of Stromal Cells in High Grade Gliomas.

S. Choi, J. Hayes, S. Shelton, L. Jones, T. Mazor, S. Fouse, M. Oldham, J. Costello

2017
18.3 Genetic Models for Social Attachment Deficits in Mental Illness.

Devanand Manoli

2017
18.3 Genetic Models for Social Attachment Deficits in Mental Illness.
2017
Genetic Characterization of Stromal Cells in High Grade Gliomas.

S. Choi, J. Hayes, S. Shelton, L. Jones, T. Mazor, S. Fouse, M. Oldham, J. Costello

2017
Abstract A30: Identifying microenvironment-dependent vulnerabilities in multiple myeloma using CRISPRi.

Poornima Ramkumar, Jaime Tawney, Diego Acosta-Alvear, Martin Kampmann

2017
Focal cerebral ß-amyloid angiopathy: A distinct clinicopathologic presentation.

Karageorgiou E, Naasan G, Pleasure SJ, Alexandrescu S, Gelfand JM, Tammewar G, Miller BL, Rabinovici GD, Grinberg LT

2017
18 F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter study.

Schonhaut DR, McMillan CT, Spina S, Dickerson BC, Siderowf A, Devous MD, Tsai R, Winer J, Russell DS, Litvan I, Roberson ED, Seeley WW, Grinberg LT, Kramer JH, Miller BL, Pressman P, Nasrallah I, Baker SL, Gomperts SN, Johnson KA, Grossman M, Jagust WJ, Boxer AL, Rabinovici GD

2017

Pages